
Transactions: Healthcare
Filter


Private placement of equity in M&E Biotech A/S (DK) — DKK 80 million

Initial public offering of Capio AB (SE) — Market value approx. SEK 2.95 billion

Option program in BioInvent International AB (SE)

Acquisition of Attendo AB (SE) by Bridgepoint (UK) — SEK 2.2 billion

Rights issue in NeuroSearch A/S (DK) — DKK 771 million

Directed new share issue in Medivir AB (SE) — SEK 281 million
Initial public offering of Bavarian Nordic Research Institute A/S (DK) — DKK 195 million


Merger of Axis Biochemicals ASA (NO) and Shield Diagnostics (UK) — NOK 970 million


Divestment of SBL Vaccin (SE) by the Swedish Government (SE) — SEK 345 million


Divestment and equity financing of Biovitrum AB (SE) — SEK 1.6 billion


Pharmacia (US) / Monsanto (US) — Spin-off — USD 3.7 billion
- Föregående
- 1
- …
- 26
- 27
- 28
- Nästa